{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T20:49:16Z","timestamp":1792097356698,"version":"4.4.0"},"reference-count":244,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Nephrol"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1038\/s41581-026-01120-x","type":"journal-article","created":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T15:33:36Z","timestamp":1788276816000},"page":"821-839","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Nucleic acid sensing pathways in kidney disease development"],"prefix":"10.1038","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5135-0981","authenticated-orcid":false,"given":"Magaiver","family":"Andrade-Silva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6472-7829","authenticated-orcid":false,"given":"Chaelin","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3584-6463","authenticated-orcid":false,"given":"Yena","family":"Jang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1005-3726","authenticated-orcid":false,"given":"Katalin","family":"Susztak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,1]]},"reference":[{"key":"1120_CR1","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1038\/s41581-022-00589-6","volume":"18","author":"S Skopelja-Gardner","year":"2022","unstructured":"Skopelja-Gardner, S., An, J. & Elkon, K. B. Role of the cGAS-STING pathway in systemic and organ-specific diseases. Nat. Rev. Nephrol. 18, 558\u2013572 https:\/\/doi.org\/10.1038\/s41581-022-00589-6 (2022).","journal-title":"Nat. Rev. Nephrol."},{"key":"1120_CR2","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1146\/annurev-immunol-032713-120156","volume":"32","author":"J Wu","year":"2014","unstructured":"Wu, J. & Chen, Z. J. Innate immune sensing and signaling of cytosolic nucleic acids. Annu. Rev. Immunol. 32, 461\u2013488 https:\/\/doi.org\/10.1146\/annurev-immunol-032713-120156 (2014).","journal-title":"Annu. Rev. Immunol."},{"key":"1120_CR3","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/j.immuni.2016.04.002","volume":"44","author":"A Roers","year":"2016","unstructured":"Roers, A., Hiller, B. & Hornung, V. Recognition of endogenous nucleic acids by the innate immune system. Immunity 44, 739\u2013754 (2016).","journal-title":"Immunity"},{"key":"1120_CR4","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1038\/ng1845","volume":"38","author":"YJ Crow","year":"2006","unstructured":"Crow, Y. J. et al. Mutations in the gene encoding the 3\u2032-5\u2032 DNA exonuclease TREX1 cause Aicardi-Gouti\u00e8res syndrome at the AGS1 locus. Nat. Genet. 38, 917\u2013920 (2006).","journal-title":"Nat. Genet."},{"key":"1120_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-020-0198-7","volume":"5","author":"Z Cheng","year":"2020","unstructured":"Cheng, Z. et al. The interactions between cGAS-STING pathway and pathogens. Signal. Transduct. Target. Ther. 5, 91 (2020).","journal-title":"Signal. Transduct. Target. Ther."},{"key":"1120_CR6","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1038\/s41586-019-1006-9","volume":"567","author":"X Gui","year":"2019","unstructured":"Gui, X. et al. Autophagy induction via STING trafficking is a primordial function of the cGAS pathway. Nature 567, 262\u2013266 (2019).","journal-title":"Nature"},{"key":"1120_CR7","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.2353\/ajpath.2006.051329","volume":"168","author":"M Kalaaji","year":"2006","unstructured":"Kalaaji, M., Mortensen, E., J\u00f8rgensen, L., Olsen, R. & Rekvig, O. P. Nephritogenic lupus antibodies recognize glomerular basement membrane-associated chromatin fragments released from apoptotic intraglomerular cells. Am. J. Pathol. 168, 1779\u20131792 (2006).","journal-title":"Am. J. Pathol."},{"key":"1120_CR8","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1007\/s10157-023-02448-5","volume":"28","author":"X Luo","year":"2024","unstructured":"Luo, X. et al. Cytosolic mtDNA\u2013cGAS\u2013STING axis contributes to sepsis-induced acute kidney injury via activating the NLRP3 inflammasome. Clin. Exp. Nephrol. 28, 375\u2013390 (2024).","journal-title":"Clin. Exp. Nephrol."},{"key":"1120_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-06247-4","volume":"14","author":"L Shi","year":"2023","unstructured":"Shi, L. et al. DUSP1 protects against ischemic acute kidney injury through stabilizing mtDNA via interaction with JNK. Cell Death Dis. 14, 724 (2023).","journal-title":"Cell Death Dis."},{"key":"1120_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2022.105145","volume":"25","author":"N Zang","year":"2022","unstructured":"Zang, N. et al. cGAS-STING activation contributes to podocyte injury in diabetic kidney disease. IScience 25, 105145 (2022).","journal-title":"IScience"},{"key":"1120_CR11","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1016\/j.celrep.2019.09.050","volume":"29","author":"H Maekawa","year":"2019","unstructured":"Maekawa, H. et al. Mitochondrial damage causes inflammation via cGAS-STING signaling in acute kidney injury. Cell Rep. 29, 1261\u20131273.e6 https:\/\/doi.org\/10.1016\/j.celrep.2019.09.050 (2019).","journal-title":"Cell Rep."},{"key":"1120_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/s41420-024-01843-5","volume":"10","author":"Y Chen","year":"2024","unstructured":"Chen, Y. et al. Mitochondrial metabolism and targeted treatment strategies in ischemic-induced acute kidney injury. Cell Death Discov. 10, 69 https:\/\/doi.org\/10.1038\/s41420-024-01843-5 (2024).","journal-title":"Cell Death Discov."},{"key":"1120_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-53798-x","volume":"15","author":"X Liang","year":"2024","unstructured":"Liang, X. et al. TET2 germline variants promote kidney disease by impairing DNA repair and activating cytosolic nucleotide sensors. Nat. Commun. 15, 9621 https:\/\/doi.org\/10.1038\/s41467-024-53798-x (2024).","journal-title":"Nat. Commun."},{"key":"1120_CR14","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1016\/j.cmet.2019.08.003","volume":"30","author":"KW Chung","year":"2019","unstructured":"Chung, K. W. et al. Mitochondrial damage and activation of the STING pathway lead to renal inflammation and fibrosis. Cell Metab. 30, 784\u2013799.e5 (2019).","journal-title":"Cell Metab."},{"key":"1120_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00502","volume":"10","author":"B Duvvuri","year":"2019","unstructured":"Duvvuri, B. & Lood, C. Cell-free DNA as a biomarker in autoimmune rheumatic diseases. Front. Immunol. 10, 502 (2019).","journal-title":"Front. Immunol."},{"key":"1120_CR16","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.jaut.2014.08.004","volume":"56","author":"GE Fragoulis","year":"2015","unstructured":"Fragoulis, G. E. et al. Impaired degradation and aberrant phagocytosis of necrotic cell debris in the peripheral blood of patients with primary Sj\u00f6gren\u2019s syndrome. J. Autoimmun. 56, 12\u201322 (2015).","journal-title":"J. Autoimmun."},{"key":"1120_CR17","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1177\/0961203311425522","volume":"21","author":"BP dos Santos","year":"2012","unstructured":"dos Santos, B. P. et al. TLR7\/8\/9 polymorphisms and their associations in systemic lupus erythematosus patients from southern Brazil. Lupus 21, 302\u2013309 https:\/\/doi.org\/10.1177\/0961203311425522 (2012).","journal-title":"Lupus"},{"key":"1120_CR18","doi-asserted-by":"publisher","first-page":"13968","DOI":"10.1038\/s41598-024-64495-6","volume":"14","author":"PP Vejvisithsakul","year":"2022","unstructured":"Vejvisithsakul, P. P. et al. Elucidating the function of STING in systemic lupus erythematosus through the STING Goldenticket mouse mutant. Sci. Rep. 14, 13968 https:\/\/doi.org\/10.1038\/s41598-024-64495-6 (2022).","journal-title":"Sci. Rep."},{"key":"1120_CR19","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.kint.2024.10.021","volume":"107","author":"M Andrade-Silva","year":"2025","unstructured":"Andrade-Silva, M. et al. The critical role of endoplasmic reticulum stress and the stimulator of interferon genes (STING) pathway in kidney fibrosis. Kidney Int. 107, 302\u2013316 (2025).","journal-title":"Kidney Int."},{"key":"1120_CR20","doi-asserted-by":"publisher","first-page":"2632","DOI":"10.1016\/j.immuni.2021.10.004","volume":"54","author":"J Wu","year":"2021","unstructured":"Wu, J. et al. APOL1 risk variants in individuals of African genetic ancestry drive endothelial cell defects that exacerbate sepsis. Immunity 54, 2632\u20132649.e6 https:\/\/doi.org\/10.1016\/j.immuni.2021.10.004 (2021).","journal-title":"Immunity"},{"key":"1120_CR21","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abi8051","volume":"7","author":"T Doke","year":"2021","unstructured":"Doke, T. et al. Genome-wide association studies identify the role of caspase-9 in kidney disease. Sci. Adv. 7, eabi8051 https:\/\/doi.org\/10.1126\/sciadv.abi8051 (2021).","journal-title":"Sci. Adv."},{"key":"1120_CR22","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1038\/s42255-023-00761-7","volume":"5","author":"T Doke","year":"2023","unstructured":"Doke, T. et al. NAD+ precursor supplementation prevents mtRNA\/RIG-I-dependent inflammation during kidney injury. Nat. Metab. 5, 414\u2013430 https:\/\/doi.org\/10.1038\/s42255-023-00761-7 (2023).","journal-title":"Nat. Metab."},{"key":"1120_CR23","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1681\/ASN.2018070687","volume":"30","author":"SY Li","year":"2019","unstructured":"Li, S. Y. et al. DNMT1 in six2 progenitor cells is essential for transposable element silencing and kidney development. J. Am. Soc. Nephrol. 30, 594\u2013609 https:\/\/doi.org\/10.1681\/ASN.2018070687 (2019).","journal-title":"J. Am. Soc. Nephrol."},{"key":"1120_CR24","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.immuni.2020.06.014","volume":"53","author":"E Bartok","year":"2020","unstructured":"Bartok, E. & Hartmann, G. Immune sensing mechanisms that discriminate self from altered self and foreign nucleic acids. Immunity 53, 54\u201377 (2020).","journal-title":"Immunity"},{"key":"1120_CR25","doi-asserted-by":"publisher","first-page":"5506","DOI":"10.1016\/j.cell.2021.09.034","volume":"184","author":"KN Miller","year":"2021","unstructured":"Miller, K. N. et al. Cytoplasmic DNA: sources, sensing, and role in aging and disease. Cell 184, 5506\u20135526 (2021).","journal-title":"Cell"},{"key":"1120_CR26","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1128\/MMBR.00061-14","volume":"79","author":"SR Paludan","year":"2015","unstructured":"Paludan, S. R. Activation and regulation of DNA-driven immune responses. Microbiol. Mol. Biol. Rev. 79, 225\u2013241 (2015).","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"1120_CR27","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00832","volume":"9","author":"S Grazioli","year":"2018","unstructured":"Grazioli, S. & Pugin, J. Mitochondrial damage-associated molecular patterns: from inflammatory signaling to human diseases. Front. Immunol. 9, 832 (2018).","journal-title":"Front. Immunol."},{"key":"1120_CR28","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1038\/s41577-020-0288-3","volume":"20","author":"J Rehwinkel","year":"2020","unstructured":"Rehwinkel, J. & Gack, M. U. RIG-I-like receptors: their regulation and roles in RNA sensing. Nat. Rev. Immunol. 20, 537\u2013551 (2020).","journal-title":"Nat. Rev. Immunol."},{"key":"1120_CR29","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1038\/s41586-018-0363-0","volume":"560","author":"A Dhir","year":"2018","unstructured":"Dhir, A. et al. Mitochondrial double-stranded RNA triggers antiviral signalling in humans. Nature 560, 238\u2013242 (2018).","journal-title":"Nature"},{"key":"1120_CR30","doi-asserted-by":"publisher","DOI":"10.2741\/4917","volume":"26","author":"S Banerjee","year":"2021","unstructured":"Banerjee, S., Thompson, W. E. & Chowdhury, I. Emerging roles of microRNAs in the regulation of Toll-like receptor (TLR)-signaling. Front. Biosci. 26, 771 (2021).","journal-title":"Front. Biosci."},{"key":"1120_CR31","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1038\/nri2873","volume":"10","author":"GY Chen","year":"2010","unstructured":"Chen, G. Y. & Nu\u00f1ez, G. Sterile inflammation: sensing and reacting to damage. Nat. Rev. Immunol. 10, 826\u2013837 (2010).","journal-title":"Nat. Rev. Immunol."},{"key":"1120_CR32","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1126\/science.1232458","volume":"339","author":"L Sun","year":"2013","unstructured":"Sun, L., Wu, J., Du, F., Chen, X. & Chen, Z. J. Cyclic GMP-AMP synthase is a cytosolic DNA sensor that activates the type I interferon pathway. Science 339, 786\u2013791 (2013).","journal-title":"Science"},{"key":"1120_CR33","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1038\/ng.975","volume":"43","author":"SM Al-Mayouf","year":"2011","unstructured":"Al-Mayouf, S. M. et al. Loss-of-function variant in DNASE1L3 causes a familial form of systemic lupus erythematosus. Nat. Genet. 43, 1186\u20131188 (2011).","journal-title":"Nat. Genet."},{"key":"1120_CR34","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1016\/j.immuni.2019.03.025","volume":"50","author":"HM Lazear","year":"2019","unstructured":"Lazear, H. M., Schoggins, J. W. & Diamond, M. S. Shared and distinct functions of type I and type III interferons. Immunity 50, 907\u2013923 (2019).","journal-title":"Immunity"},{"key":"1120_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41421-020-0167-x","volume":"6","author":"D Zheng","year":"2020","unstructured":"Zheng, D., Liwinski, T. & Elinav, E. Inflammasome activation and regulation: toward a better understanding of complex mechanisms. Cell Discov. 6, 36 (2020).","journal-title":"Cell Discov."},{"key":"1120_CR36","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1126\/science.1229963","volume":"339","author":"J Wu","year":"2013","unstructured":"Wu, J. et al. Cyclic GMP-AMP is an endogenous second messenger in innate immune signaling by cytosolic DNA. Science 339, 826\u2013830 (2013).","journal-title":"Science"},{"key":"1120_CR37","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.molcel.2013.05.022","volume":"51","author":"X Zhang","year":"2013","unstructured":"Zhang, X. et al. Cyclic GMP-AMP containing mixed phosphodiester linkages is an endogenous high-affinity ligand for STING. Mol. Cell 51, 226\u2013235 (2013).","journal-title":"Mol. Cell"},{"key":"1120_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2020.03.056","volume":"31","author":"KR Balka","year":"2020","unstructured":"Balka, K. R. et al. TBK1 and IKK\u03b5 act redundantly to mediate STING-induced NF-\u03baB responses in myeloid cells. Cell Rep. 31, 107492 (2020).","journal-title":"Cell Rep."},{"key":"1120_CR39","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaa2630","volume":"347","author":"S Liu","year":"2015","unstructured":"Liu, S. et al. Phosphorylation of innate immune adaptor proteins MAVS, STING, and TRIF induces IRF3 activation. Science 347, aaa2630 (2015).","journal-title":"Science"},{"key":"1120_CR40","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1016\/j.immuni.2013.10.019","volume":"39","author":"X Li","year":"2013","unstructured":"Li, X. et al. Cyclic GMP-AMP synthase is activated by double-stranded DNA-induced oligomerization. Immunity 39, 1019\u20131031 (2013).","journal-title":"Immunity"},{"key":"1120_CR41","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.cell.2018.06.026","volume":"174","author":"W Zhou","year":"2018","unstructured":"Zhou, W. et al. Structure of the human cGAS\u2013DNA complex reveals enhanced control of immune surveillance. Cell 174, 300\u2013311.e311 (2018).","journal-title":"Cell"},{"key":"1120_CR42","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1038\/ni.1932","volume":"11","author":"L Unterholzner","year":"2010","unstructured":"Unterholzner, L. et al. IFI16 is an innate immune sensor for intracellular DNA. Nat. Immunol. 11, 997\u20131004 (2010).","journal-title":"Nat. Immunol."},{"key":"1120_CR43","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1038\/ni.2091","volume":"12","author":"Z Zhang","year":"2011","unstructured":"Zhang, Z. et al. The helicase DDX41 senses intracellular DNA mediated by the adaptor STING in dendritic cells. Nat. Immunol. 12, 959\u2013965 (2011).","journal-title":"Nat. Immunol."},{"key":"1120_CR44","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1038\/s41586-023-06373-1","volume":"620","author":"MF Gulen","year":"2023","unstructured":"Gulen, M. F. et al. cGAS\u2013STING drives ageing-related inflammation and neurodegeneration. Nature 620, 374\u2013380 (2023).","journal-title":"Nature"},{"key":"1120_CR45","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/s41580-020-0244-x","volume":"21","author":"K-P Hopfner","year":"2020","unstructured":"Hopfner, K.-P. & Hornung, V. Molecular mechanisms and cellular functions of cGAS\u2013STING signalling. Nat. Rev. Mol. Cell Biol. 21, 501\u2013521 (2020).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"1120_CR46","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1038\/s43018-020-0028-4","volume":"1","author":"JA Carozza","year":"2020","unstructured":"Carozza, J. A. et al. Extracellular cGAMP is a cancer-cell-produced immunotransmitter involved in radiation-induced anticancer immunity. Nat. Cancer 1, 184\u2013196 (2020).","journal-title":"Nat. Cancer"},{"key":"1120_CR47","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.molcel.2019.05.006","volume":"75","author":"C Ritchie","year":"2019","unstructured":"Ritchie, C., Cordova, A. F., Hess, G. T., Bassik, M. C. & Li, L. SLC19A1 Is an Importer of the Immunotransmitter cGAMP. Mol. Cell 75, 372\u2013381.e5 https:\/\/doi.org\/10.1016\/j.molcel.2019.05.006 (2019).","journal-title":"Mol. Cell"},{"key":"1120_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.112185","volume":"42","author":"L Zhang","year":"2023","unstructured":"Zhang, L. et al. NF-\u03baB activation enhances STING signaling by altering microtubule-mediated STING trafficking. Cell Rep. 42, 112185 https:\/\/doi.org\/10.1016\/j.celrep.2023.112185 (2023).","journal-title":"Cell Rep."},{"key":"1120_CR49","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1126\/science.adf8974","volume":"381","author":"B Liu","year":"2023","unstructured":"Liu, B. et al. Human STING is a proton channel. Science 381, 508\u2013514 https:\/\/doi.org\/10.1126\/science.adf8974 (2023).","journal-title":"Science"},{"key":"1120_CR50","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1016\/j.cell.2025.01.027","volume":"188","author":"S Poddar","year":"2025","unstructured":"Poddar, S. et al. ArfGAP2 promotes STING proton channel activity, cytokine transit, and autoinflammation. Cell 188, 1605\u20131622.e26 https:\/\/doi.org\/10.1016\/j.cell.2025.01.027 (2025).","journal-title":"Cell"},{"key":"1120_CR51","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1038\/s41577-019-0165-0","volume":"19","author":"KV Swanson","year":"2019","unstructured":"Swanson, K. V., Deng, M. & Ting, J. P. The NLRP3 inflammasome: molecular activation and regulation to therapeutics. Nat. Rev. Immunol. 19, 477\u2013489 https:\/\/doi.org\/10.1038\/s41577-019-0165-0 (2019).","journal-title":"Nat. Rev. Immunol."},{"key":"1120_CR52","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.immuni.2012.01.009","volume":"36","author":"K Shimada","year":"2012","unstructured":"Shimada, K. et al. Oxidized mitochondrial DNA activates the NLRP3 inflammasome during apoptosis. Immunity 36, 401\u2013414 https:\/\/doi.org\/10.1016\/j.immuni.2012.01.009 (2012).","journal-title":"Immunity"},{"key":"1120_CR53","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1038\/nature07725","volume":"458","author":"V Hornung","year":"2009","unstructured":"Hornung, V. et al. AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC. Nature 458, 514\u2013518 (2009).","journal-title":"Nature"},{"key":"1120_CR54","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/nature18629","volume":"535","author":"X Liu","year":"2016","unstructured":"Liu, X. et al. Inflammasome-activated gasdermin D causes pyroptosis by forming membrane pores. Nature 535, 153\u2013158 (2016).","journal-title":"Nature"},{"key":"1120_CR55","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms8827","volume":"6","author":"SR Morrone","year":"2015","unstructured":"Morrone, S. R. et al. Assembly-driven activation of the AIM2 foreign-dsDNA sensor provides a polymerization template for downstream ASC. Nat. Commun. 6, 7827 https:\/\/doi.org\/10.1038\/ncomms8827 (2015).","journal-title":"Nat. Commun."},{"key":"1120_CR56","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1038\/ni.1859","volume":"11","author":"T Fernandes-Alnemri","year":"2010","unstructured":"Fernandes-Alnemri, T. et al. The AIM2 inflammasome is critical for innate immunity to Francisella tularensis. Nat. Immunol. 11, 385\u2013393 https:\/\/doi.org\/10.1038\/ni.1859 (2010).","journal-title":"Nat. Immunol."},{"key":"1120_CR57","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/nature04734","volume":"441","author":"H Kato","year":"2006","unstructured":"Kato, H. et al. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 441, 101\u2013105 (2006).","journal-title":"Nature"},{"key":"1120_CR58","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1073\/pnas.0912986107","volume":"107","author":"T Satoh","year":"2010","unstructured":"Satoh, T. et al. LGP2 is a positive regulator of RIG-I- and MDA5-mediated antiviral responses. Proc. Natl Acad. Sci. 107, 1512\u20131517 (2010).","journal-title":"Proc. Natl Acad. Sci."},{"key":"1120_CR59","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/j.cell.2011.06.041","volume":"146","author":"F Hou","year":"2011","unstructured":"Hou, F. et al. MAVS forms functional prion-like aggregates to activate and propagate antiviral innate immune response. Cell 146, 448\u2013461 (2011).","journal-title":"Cell"},{"key":"1120_CR60","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1126\/science.1132505","volume":"314","author":"V Hornung","year":"2006","unstructured":"Hornung, V. et al. 5\u2019-Triphosphate RNA is the ligand for RIG-I. Science 314, 994\u2013997 (2006).","journal-title":"Science"},{"key":"1120_CR61","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/nri3850","volume":"15","author":"YJ Crow","year":"2015","unstructured":"Crow, Y. J. & Manel, N. Aicardi\u2013Gouti\u00e8res syndrome and the type I interferonopathies. Nat. Rev. Immunol. 15, 429\u2013440 (2015).","journal-title":"Nat. Rev. Immunol."},{"key":"1120_CR62","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01763","volume":"10","author":"MM Lamers","year":"2019","unstructured":"Lamers, M. M., Van den Hoogen, B. G. & Haagmans, B. L. ADAR1:\u201cEditor-in-Chief\u201d of cytoplasmic innate immunity. Front. Immunol. 10, 1763 (2019).","journal-title":"Front. Immunol."},{"key":"1120_CR63","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1038\/ni.1863","volume":"11","author":"T Kawai","year":"2010","unstructured":"Kawai, T. & Akira, S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat. Immunol. 11, 373\u2013384 (2010).","journal-title":"Nat. Immunol."},{"key":"1120_CR64","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1038\/s41577-021-00577-0","volume":"22","author":"NA Lind","year":"2022","unstructured":"Lind, N. A., Rael, V. E., Pestal, K., Liu, B. & Barton, G. M. Regulation of the nucleic acid-sensing Toll-like receptors. Nat. Rev. Immunol. 22, 224\u2013235 (2022).","journal-title":"Nat. Rev. Immunol."},{"key":"1120_CR65","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1084\/jem.20050914","volume":"202","author":"FJ Barrat","year":"2005","unstructured":"Barrat, F. J. et al. Nucleic acids of mammalian origin can act as endogenous ligands for Toll-like receptors and may promote systemic lupus erythematosus. J. Exp. Med. 202, 1131\u20131139 (2005).","journal-title":"J. Exp. Med."},{"key":"1120_CR66","doi-asserted-by":"publisher","first-page":"3365","DOI":"10.1681\/ASN.2006030263","volume":"17","author":"RD Pawar","year":"2006","unstructured":"Pawar, R. D. et al. Ligands to nucleic acid-specific Toll-like receptors and the onset of lupus nephritis. J. Am. Soc. Nephrol. 17, 3365\u20133373 (2006).","journal-title":"J. Am. Soc. Nephrol."},{"key":"1120_CR67","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1172\/JCI37829","volume":"119","author":"C Brooks","year":"2009","unstructured":"Brooks, C., Wei, Q., Cho, S.-G. & Dong, Z. Regulation of mitochondrial dynamics in acute kidney injury in cell culture and rodent models. J. Clin. Invest. 119, 1275\u20131285 (2009).","journal-title":"J. Clin. Invest."},{"key":"1120_CR68","doi-asserted-by":"publisher","first-page":"4003","DOI":"10.1172\/JCI58662","volume":"121","author":"M Tran","year":"2011","unstructured":"Tran, M. et al. PGC-1\u03b1 promotes recovery after acute kidney injury during systemic inflammation in mice. J. Clin. invest. 121, 4003\u20134014 (2011).","journal-title":"J. Clin. invest."},{"key":"1120_CR69","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/nrneph.2015.214","volume":"12","author":"F Emma","year":"2016","unstructured":"Emma, F., Montini, G., Parikh, S. M. & Salviati, L. Mitochondrial dysfunction in inherited renal disease and acute kidney injury. Nat. Rev. Nephrol. 12, 267\u2013280 (2016).","journal-title":"Nat. Rev. Nephrol."},{"key":"1120_CR70","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1681\/ASN.2012080786","volume":"24","author":"DJ Parekh","year":"2013","unstructured":"Parekh, D. J. et al. Tolerance of the human kidney to isolated controlled ischemia. J. Am. Soc. Nephrol. 24, 506\u2013517 (2013).","journal-title":"J. Am. Soc. Nephrol."},{"key":"1120_CR71","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/s41577-022-00760-x","volume":"23","author":"S Marchi","year":"2023","unstructured":"Marchi, S., Guilbaud, E., Tait, S. W., Yamazaki, T. & Galluzzi, L. Mitochondrial control of inflammation. Nat. Rev. Immunol. 23, 159\u2013173 (2023).","journal-title":"Nat. Rev. Immunol."},{"key":"1120_CR72","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/8074936","volume":"2018","author":"Q Hu","year":"2018","unstructured":"Hu, Q. et al. Urinary mitochondrial DNA identifies renal dysfunction and mitochondrial damage in sepsis-induced acute kidney injury. Oxid. Med. Cell. Longev. 2018, 8074936 (2018).","journal-title":"Oxid. Med. Cell. Longev."},{"key":"1120_CR73","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1038\/ki.2015.240","volume":"88","author":"RM Whitaker","year":"2015","unstructured":"Whitaker, R. M. et al. Urinary mitochondrial DNA is a biomarker of mitochondrial disruption and renal dysfunction in acute kidney injury. Kidney Int. 88, 1336\u20131344 (2015).","journal-title":"Kidney Int."},{"key":"1120_CR74","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1038\/nrneph.2017.2","volume":"13","author":"LS Chawla","year":"2017","unstructured":"Chawla, L. S. et al. Acute kidney disease and renal recovery: consensus report of the Acute Disease Quality Initiative (ADQI) 16 Workgroup. Nat. Rev. Nephrol. 13, 241\u2013257 (2017).","journal-title":"Nat. Rev. Nephrol."},{"key":"1120_CR75","volume":"2","author":"K Group","year":"2012","unstructured":"Group, K. KDIGO clinical practice guideline for acute kidney injury. Kidney Int. Suppl. 2, 1 (2012).","journal-title":"Kidney Int. Suppl."},{"key":"1120_CR76","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1038\/nrneph.2015.3","volume":"11","author":"DA Ferenbach","year":"2015","unstructured":"Ferenbach, D. A. & Bonventre, J. V. Mechanisms of maladaptive repair after AKI leading to accelerated kidney ageing and CKD. Nat. Rev. Nephrol. 11, 264\u2013276 (2015).","journal-title":"Nat. Rev. Nephrol."},{"key":"1120_CR77","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.94716","volume":"2","author":"J Liu","year":"2017","unstructured":"Liu, J. et al. Molecular characterization of the transition from acute to chronic kidney injury following ischemia\/reperfusion. JCI insight 2, e94716 (2017).","journal-title":"JCI insight"},{"key":"1120_CR78","doi-asserted-by":"publisher","DOI":"10.1126\/science.aao6047","volume":"359","author":"K McArthur","year":"2018","unstructured":"McArthur, K. et al. BAK\/BAX macropores facilitate mitochondrial herniation and mtDNA efflux during apoptosis. Science 359, eaao6047 (2018).","journal-title":"Science"},{"key":"1120_CR79","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/9985603","volume":"2021","author":"L Jin","year":"2021","unstructured":"Jin, L., Yu, B., Armando, I. & Han, F. Mitochondrial DNA-mediated inflammation in acute kidney injury and chronic kidney disease. Oxid. Med. Cell. Longev. 2021, 9985603 (2021).","journal-title":"Oxid. Med. Cell. Longev."},{"key":"1120_CR80","doi-asserted-by":"publisher","first-page":"4461","DOI":"10.2147\/JIR.S423232","volume":"16","author":"C Sun","year":"2023","unstructured":"Sun, C. et al. The activation of cGAS-STING in acute kidney injury. J. Inflamm. Res. 16, 4461\u20134470 (2023).","journal-title":"J. Inflamm. Res."},{"key":"1120_CR81","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20123011","volume":"20","author":"SJ Holditch","year":"2019","unstructured":"Holditch, S. J., Brown, C. N., Lombardi, A. M., Nguyen, K. N. & Edelstein, C. L. Recent advances in models, mechanisms, biomarkers, and interventions in cisplatin-induced acute kidney injury. Int. J. Mol. Sci. 20, 3011 (2019).","journal-title":"Int. J. Mol. Sci."},{"key":"1120_CR82","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2017040381","volume":"29","author":"Y Guo","year":"2017","unstructured":"Guo, Y. et al. MicroRNA-709 mediates acute tubular injury through effects on mitochondrial function. J. Am. Soc. Nephrol. 29, 449 (2017).","journal-title":"J. Am. Soc. Nephrol."},{"key":"1120_CR83","doi-asserted-by":"publisher","first-page":"F608","DOI":"10.1152\/ajprenal.00554.2020","volume":"320","author":"W Gong","year":"2021","unstructured":"Gong, W. et al. The novel STING antagonist H151 ameliorates cisplatin-induced acute kidney injury and mitochondrial dysfunction. Am. J. Physiol. Renal Physiol. 320, F608\u2013F616 (2021).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"1120_CR84","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1021\/acs.molpharmaceut.2c00520","volume":"20","author":"X Qi","year":"2022","unstructured":"Qi, X. et al. Myricetin-loaded nanomicelles protect against cisplatin-induced acute kidney injury by inhibiting the DNA damage-cGAS\u2013STING signaling pathway. Mol. Pharm. 20, 136\u2013146 (2022).","journal-title":"Mol. Pharm."},{"key":"1120_CR85","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.987979","volume":"13","author":"G C\u00f3rdoba-David","year":"2022","unstructured":"C\u00f3rdoba-David, G. et al. Crosstalk between TBK1\/IKK\u03b5 and the type I interferon pathway contributes to tubulointerstitial inflammation and kidney tubular injury. Front. Pharmacol. 13, 987979 (2022).","journal-title":"Front. Pharmacol."},{"key":"1120_CR86","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1007\/s10753-024-02081-8","volume":"48","author":"Y Dong","year":"2025","unstructured":"Dong, Y. et al. Non-canonical STING-PERK pathway modulation of cellular senescence and therapeutic response in sepsis-associated acute kidney injury. Inflammation 48, 696\u2013712 (2025).","journal-title":"Inflammation"},{"key":"1120_CR87","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-024-06600-1","volume":"15","author":"Y Cao","year":"2024","unstructured":"Cao, Y. et al. STING contributes to lipopolysaccharide-induced tubular cell inflammation and pyroptosis by activating endoplasmic reticulum stress in acute kidney injury. Cell Death Dis. 15, 217 (2024).","journal-title":"Cell Death Dis."},{"key":"1120_CR88","doi-asserted-by":"publisher","first-page":"F558","DOI":"10.1152\/ajprenal.00004.2023","volume":"324","author":"Z Hu","year":"2023","unstructured":"Hu, Z., Zhang, F., Brenner, M., Jacob, A. & Wang, P. The protective effect of H151, a novel STING inhibitor, in renal ischemia-reperfusion-induced acute kidney injury. Am. J. Physiol. Renal Physiol. 324, F558\u2013F567 (2023).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"1120_CR89","doi-asserted-by":"publisher","first-page":"2658","DOI":"10.1681\/ASN.2015070748","volume":"27","author":"L Mark\u00f3","year":"2016","unstructured":"Mark\u00f3, L. et al. Tubular epithelial NF-\u03baB activity regulates ischemic AKI. J. Am. Soc. Nephrol. 27, 2658\u20132669 https:\/\/doi.org\/10.1681\/ASN.2015070748 (2016).","journal-title":"J. Am. Soc. Nephrol."},{"key":"1120_CR90","doi-asserted-by":"publisher","first-page":"F857","DOI":"10.1152\/ajprenal.00547.2010","volume":"300","author":"X Wan","year":"2011","unstructured":"Wan, X. Small interfering RNA targeting IKK\u03b2 prevents renal ischemia-reperfusion injury in rats. Am. J. Physiol. Renal Physiol. 300, F857\u2013F863 (2011).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"1120_CR91","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.116.005092","volume":"6","author":"FL Johnson","year":"2017","unstructured":"Johnson, F. L. Inhibition of I\u03baB kinase at 24 hours after acute kidney injury improves recovery of renal function and attenuates fibrosis. J. Am. Heart Assoc. 6, e005092 https:\/\/doi.org\/10.1161\/JAHA.116.005092 (2017).","journal-title":"J. Am. Heart Assoc."},{"key":"1120_CR92","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/j.chembiol.2020.03.016","volume":"27","author":"A Belavgeni","year":"2020","unstructured":"Belavgeni, A., Meyer, C., Stumpf, J., Hugo, C. & Linkermann, A. Ferroptosis and necroptosis in the kidney. Cell Chem. Biol. 27, 448\u2013462 (2020).","journal-title":"Cell Chem. Biol."},{"key":"1120_CR93","doi-asserted-by":"publisher","first-page":"19395","DOI":"10.1074\/jbc.RA119.010949","volume":"294","author":"L Su","year":"2019","unstructured":"Su, L. et al. Pannexin 1 mediates ferroptosis that contributes to renal ischemia\/reperfusion injury. J. Biol. Chem. 294, 19395\u201319404 (2019).","journal-title":"J. Biol. Chem."},{"key":"1120_CR94","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.freeradbiomed.2023.08.025","volume":"208","author":"L Jin","year":"2023","unstructured":"Jin, L. et al. STING promotes ferroptosis through NCOA4-dependent ferritinophagy in acute kidney injury. Free. Radic. Biol. Med. 208, 348\u2013360 (2023).","journal-title":"Free. Radic. Biol. Med."},{"key":"1120_CR95","doi-asserted-by":"publisher","first-page":"F1105","DOI":"10.1152\/ajprenal.00285.2020","volume":"319","author":"M Jiang","year":"2020","unstructured":"Jiang, M. et al. Mitochondrial dysfunction and the AKI-to-CKD transition. Am. J. Physiol. Renal Physiology 319, F1105\u2013F1116 (2020).","journal-title":"Am. J. Physiol. Renal Physiology"},{"key":"1120_CR96","doi-asserted-by":"publisher","DOI":"10.1016\/j.nantod.2024.102209","volume":"55","author":"Y Shen","year":"2024","unstructured":"Shen, Y. et al. STING antagonist-loaded renal tubule epithelial cell-mimicking nanoparticles ameliorate acute kidney injury by orchestrating innate and adaptive immunity. Nano Today 55, 102209 (2024).","journal-title":"Nano Today"},{"key":"1120_CR97","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.940716","volume":"13","author":"H Zeng","year":"2022","unstructured":"Zeng, H. et al. Pharmacological inhibition of STING\/TBK1 signaling attenuates myeloid fibroblast activation and macrophage to myofibroblast transition in renal fibrosis. Front. Pharmacol. 13, 940716 (2022).","journal-title":"Front. Pharmacol."},{"key":"1120_CR98","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.freeradbiomed.2023.09.011","volume":"208","author":"A Jiang","year":"2023","unstructured":"Jiang, A., Liu, J., Wang, Y. & Zhang, C. cGAS-STING signaling pathway promotes hypoxia-induced renal fibrosis by regulating PFKFB3-mediated glycolysis. Free. Radic. Biol. Med. 208, 516\u2013529 (2023).","journal-title":"Free. Radic. Biol. Med."},{"key":"1120_CR99","doi-asserted-by":"publisher","DOI":"10.1186\/s12882-019-1549-x","volume":"20","author":"CC Chang","year":"2019","unstructured":"Chang, C. C. et al. Urinary cell-free mitochondrial and nuclear deoxyribonucleic acid correlates with the prognosis of chronic kidney diseases. BMC Nephrol. 20, 391 https:\/\/doi.org\/10.1186\/s12882-019-1549-x (2019).","journal-title":"BMC Nephrol."},{"key":"1120_CR100","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1377874","volume":"15","author":"M Zhang","year":"2024","unstructured":"Zhang, M. et al. Effects of cell-free DNA on kidney disease and intervention strategies. Front. Pharmacol. 15, 1377874 https:\/\/doi.org\/10.3389\/fphar.2024.1377874 (2024).","journal-title":"Front. Pharmacol."},{"key":"1120_CR101","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2023.110777","volume":"109","author":"X Yang","year":"2023","unstructured":"Yang, X. et al. STING deletion alleviates podocyte injury through suppressing inflammation by targeting NLRP3 in diabetic kidney disease. Cell Signal. 109, 110777 https:\/\/doi.org\/10.1016\/j.cellsig.2023.110777 (2023).","journal-title":"Cell Signal."},{"key":"1120_CR102","doi-asserted-by":"publisher","first-page":"2153","DOI":"10.1681\/ASN.2021101286","volume":"33","author":"A Mitrofanova","year":"2022","unstructured":"Mitrofanova, A. et al. Activation of stimulator of IFN genes (STING) causes proteinuria and contributes to glomerular diseases. J. Am. Soc. Nephrol. 33, 2153\u20132173 https:\/\/doi.org\/10.1681\/ASN.2021101286 (2022).","journal-title":"J. Am. Soc. Nephrol."},{"key":"1120_CR103","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2024.116373","volume":"226","author":"L Liang","year":"2024","unstructured":"Liang, L. Polydatin attenuates diabetic renal inflammatory fibrosis via the inhibition of STING pathway. Biochem. Pharmacol. 226, 116373 https:\/\/doi.org\/10.1016\/j.bcp.2024.116373 (2024).","journal-title":"Biochem. Pharmacol."},{"key":"1120_CR104","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.ajpath.2025.10.013","volume":"196","author":"MZ Syeda","year":"2026","unstructured":"Syeda, M. Z. et al. Stimulator of interferon genes is a fine-tuner, but not a prime mover, of kidney inflammation. Am. J. Pathol. 196, 515\u2013531 (2026).","journal-title":"Am. J. Pathol."},{"key":"1120_CR105","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1161\/CIRCULATIONAHA.124.071351","volume":"153","author":"F Li","year":"2026","unstructured":"Li, F. et al. Cell-specific inducible human APOL1 risk variant expression in mice causes hypertension and renal Damage. Circulation 153, 396\u2013414 https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.124.071351 (2026).","journal-title":"Circulation"},{"key":"1120_CR106","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.174126","volume":"10","author":"S Khedr","year":"2024","unstructured":"Khedr, S. et al. Role of cGAS\/STING pathway in aging and sexual dimorphism in diabetic kidney disease. JCI Insight 10, e174126 https:\/\/doi.org\/10.1172\/jci.insight.174126 (2024).","journal-title":"JCI Insight"},{"key":"1120_CR107","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2023.104975","volume":"299","author":"K Myakala","year":"2023","unstructured":"Myakala, K. et al. NAD metabolism modulates inflammation and mitochondria function in diabetic kidney disease. J. Biol. Chem. 299, 104975 https:\/\/doi.org\/10.1016\/j.jbc.2023.104975 (2023).","journal-title":"J. Biol. Chem."},{"key":"1120_CR108","doi-asserted-by":"publisher","DOI":"10.34067\/KID.0000001099","volume":"7","author":"Q Zheng","year":"2026","unstructured":"Zheng, Q. et al. Dapagliflozin reduces kidney inflammation in Alport syndrome by inhibiting the Stimulator of IFN Genes pathway in renal tubular epithelial cells. Kidney360 7, 969 (2026).","journal-title":"Kidney360"},{"key":"1120_CR109","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1002\/path.6177","volume":"261","author":"J Garc\u00eda-Gim\u00e9nez","year":"2023","unstructured":"Garc\u00eda-Gim\u00e9nez, J. STING1 deficiency ameliorates immune-mediated crescentic glomerulonephritis in mice. J. Pathol. 261, 309\u2013322 https:\/\/doi.org\/10.1002\/path.6177 (2023).","journal-title":"J. Pathol."},{"key":"1120_CR110","doi-asserted-by":"publisher","DOI":"10.1080\/08916934.2023.2281235","volume":"56","author":"X Li","year":"2023","unstructured":"Li, X. et al. SMURF1 activates the cGAS\/STING\/IFN-1 signal axis by mediating YY1 ubiquitination to accelerate the progression of lupus nephritis. Autoimmunity 56, 2281235 https:\/\/doi.org\/10.1080\/08916934.2023.2281235 (2023).","journal-title":"Autoimmunity"},{"key":"1120_CR111","doi-asserted-by":"publisher","DOI":"10.1007\/s12038-023-00381-z","volume":"49","author":"J Chen","year":"2024","unstructured":"Chen, J. et al. STING upregulation mediates ferroptosis and inflammatory response in lupus nephritis by upregulating TBK1 and activating NF-\u03baB signal pathway. J. Biosci. 49, 9 (2024).","journal-title":"J. Biosci."},{"key":"1120_CR112","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1038\/s41588-024-01802-x","volume":"56","author":"A Abedini","year":"2024","unstructured":"Abedini, A. et al. Single-cell multi-omic and spatial profiling of human kidneys implicates the fibrotic microenvironment in kidney disease progression. Nat. Genet. 56, 1712\u20131724 https:\/\/doi.org\/10.1038\/s41588-024-01802-x (2024).","journal-title":"Nat. Genet."},{"key":"1120_CR113","doi-asserted-by":"publisher","first-page":"3084","DOI":"10.1016\/j.ymthe.2023.07.026","volume":"31","author":"L Gao","year":"2023","unstructured":"Gao, L. et al. STING\/ACSL4 axis-dependent ferroptosis and inflammation promote hypertension-associated chronic kidney disease. Mol. Ther. 31, 3084\u20133103 https:\/\/doi.org\/10.1016\/j.ymthe.2023.07.026 (2023).","journal-title":"Mol. Ther."},{"key":"1120_CR114","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1038\/s41586-023-05770-w","volume":"615","author":"V Zecchini","year":"2023","unstructured":"Zecchini, V. et al. Fumarate induces vesicular release of mtDNA to drive innate immunity. Nature 615, 499\u2013506 https:\/\/doi.org\/10.1038\/s41586-023-05770-w (2023).","journal-title":"Nature"},{"key":"1120_CR115","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1681\/ASN.2015030302","volume":"27","author":"YH You","year":"2016","unstructured":"You, Y. H., Quach, T., Saito, R., Pham, J. & Sharma, K. Metabolomics reveals a key role for fumarate in mediating the effects of NADPH oxidase 4 in diabetic kidney disease. J. Am. Soc. Nephrol. 27, 466\u2013481 https:\/\/doi.org\/10.1681\/ASN.2015030302 (2016).","journal-title":"J. Am. Soc. Nephrol."},{"key":"1120_CR116","doi-asserted-by":"publisher","DOI":"10.1111\/apha.14121","volume":"240","author":"ZL Li","year":"2024","unstructured":"Li, Z. L. et al. Mitochondrial fumarate promotes ischemia\/reperfusion-induced tubular injury. Acta Physiol. 240, e14121 https:\/\/doi.org\/10.1111\/apha.14121 (2024).","journal-title":"Acta Physiol."},{"key":"1120_CR117","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-36212-w","volume":"14","author":"P Dhillon","year":"2023","unstructured":"Dhillon, P. et al. Increased levels of endogenous retroviruses trigger fibroinflammation and play a role in kidney disease development. Nat. Commun. 14, 559 https:\/\/doi.org\/10.1038\/s41467-023-36212-w (2023).","journal-title":"Nat. Commun."},{"key":"1120_CR118","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1681\/ASN.0000000000000428","volume":"35","author":"YC Tsai","year":"2024","unstructured":"Tsai, Y. C. et al. METTL3-mediated N 6 -methyladenosine mRNA modification and cGAS-STING pathway activity in kidney fibrosis. J. Am. Soc. Nephrol. 35, 1312\u20131329 https:\/\/doi.org\/10.1681\/ASN.0000000000000428 (2024).","journal-title":"J. Am. Soc. Nephrol."},{"key":"1120_CR119","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1038\/s41556-022-00894-z","volume":"24","author":"D Zhang","year":"2022","unstructured":"Zhang, D. et al. A non-canonical cGAS\u2013STING\u2013PERK pathway facilitates the translational program critical for senescence and organ fibrosis. Nat. Cell Biol. 24, 766\u2013782 (2022).","journal-title":"Nat. Cell Biol."},{"key":"1120_CR120","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1681\/ASN.2017080863","volume":"29","author":"T Komada","year":"2018","unstructured":"Komada, T. et al. Macrophage uptake of necrotic cell DNA activates the AIM2 inflammasome to regulate a proinflammatory phenotype in CKD. J. Am. Soc. Nephrol. 29, 1165\u20131181 https:\/\/doi.org\/10.1681\/ASN.2017080863 (2018).","journal-title":"J. Am. Soc. Nephrol."},{"key":"1120_CR121","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.immuni.2012.02.014","volume":"36","author":"T Jin","year":"2012","unstructured":"Jin, T. et al. Structures of the HIN domain: DNA complexes reveal ligand binding and activation mechanisms of the AIM2 inflammasome and IFI16 receptor. Immunity 36, 561\u2013571 (2012).","journal-title":"Immunity"},{"key":"1120_CR122","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.112302","volume":"42","author":"R Nakamichi","year":"2023","unstructured":"Nakamichi, R. et al. DNA-damaged podocyte-CD8 T cell crosstalk exacerbates kidney injury by altering DNA methylation. Cell Rep. 42, 112302 https:\/\/doi.org\/10.1016\/j.celrep.2023.112302 (2023).","journal-title":"Cell Rep."},{"key":"1120_CR123","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1038\/s41581-022-00671-z","volume":"19","author":"JI Garaycoechea","year":"2023","unstructured":"Garaycoechea, J. I., Quinlan, C. & Luijsterburg, M. S. Pathological consequences of DNA damage in the kidney. Nat. Rev. Nephrol. 19, 229\u2013243 https:\/\/doi.org\/10.1038\/s41581-022-00671-z (2023).","journal-title":"Nat. Rev. Nephrol."},{"key":"1120_CR124","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1038\/s41440-023-01169-2","volume":"46","author":"N Yoshimoto","year":"2023","unstructured":"Yoshimoto, N. et al. Significance of podocyte DNA damage and glomerular DNA methylation in CKD patients with proteinuria. Hypertens. Res. 46, 1000\u20131008 https:\/\/doi.org\/10.1038\/s41440-023-01169-2 (2023).","journal-title":"Hypertens. Res."},{"key":"1120_CR125","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-60420-9","volume":"10","author":"A Hishikawa","year":"2020","unstructured":"Hishikawa, A. et al. DNA damage and expression of DNA methylation modulators in urine-derived cells of patients with hypertension and diabetes. Sci. Rep. 10, 3377 https:\/\/doi.org\/10.1038\/s41598-020-60420-9 (2020).","journal-title":"Sci. Rep."},{"key":"1120_CR126","doi-asserted-by":"publisher","DOI":"10.1172\/JCI136329","volume":"131","author":"J Wu","year":"2021","unstructured":"Wu, J. et al. The key role of NLRP3 and STING in APOL1-associated podocytopathy. J. Clin. Invest. 131, e136329 https:\/\/doi.org\/10.1172\/JCI136329 (2021).","journal-title":"J. Clin. Invest."},{"key":"1120_CR127","doi-asserted-by":"publisher","DOI":"10.1038\/srep24667","volume":"6","author":"J Chun","year":"2016","unstructured":"Chun, J. et al. NLRP3 localizes to the tubular epithelium in human kidney and correlates with outcome in IgA nephropathy. Sci. Rep. 6, 24667 https:\/\/doi.org\/10.1038\/srep24667 (2016).","journal-title":"Sci. Rep."},{"key":"1120_CR128","doi-asserted-by":"publisher","DOI":"10.3390\/cells8040328","volume":"8","author":"JH Bae","year":"2019","unstructured":"Bae, J. H. et al. Circulating cell-free mtDNA contributes to AIM2 inflammasome-mediated chronic inflammation in patients with type 2 diabetes. Cells 8, 328 https:\/\/doi.org\/10.3390\/cells8040328 (2019).","journal-title":"Cells"},{"key":"1120_CR129","doi-asserted-by":"publisher","first-page":"e22","DOI":"10.1016\/j.diabres.2009.07.002","volume":"86","author":"AN Malik","year":"2009","unstructured":"Malik, A. N., Shahni, R. & Iqbal, M. M. Increased peripheral blood mitochondrial DNA in type 2 diabetic patients with nephropathy. Diabetes Res. Clin. Pract. 86, e22\u2013e24 https:\/\/doi.org\/10.1016\/j.diabres.2009.07.002 (2009).","journal-title":"Diabetes Res. Clin. Pract."},{"key":"1120_CR130","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1042\/cs20211075","volume":"136","author":"Y Wu","year":"2022","unstructured":"Wu, Y. et al. AIM2 inflammasome contributes to aldosterone-induced renal injury via endoplasmic reticulum stress. Clin. Sci. 136, 103\u2013120 https:\/\/doi.org\/10.1042\/cs20211075 (2022).","journal-title":"Clin. Sci."},{"key":"1120_CR131","doi-asserted-by":"publisher","first-page":"2799","DOI":"10.4049\/jimmunol.2100483","volume":"207","author":"H Chung","year":"2021","unstructured":"Chung, H. et al. AIM2 suppresses inflammation and epithelial cell proliferation during glomerulonephritis. J. Immunol. 207, 2799\u20132812 https:\/\/doi.org\/10.4049\/jimmunol.2100483 (2021).","journal-title":"J. Immunol."},{"key":"1120_CR132","doi-asserted-by":"publisher","first-page":"2487","DOI":"10.1038\/s41418-022-01033-9","volume":"29","author":"C Baatarjav","year":"2022","unstructured":"Baatarjav, C. et al. dsDNA-induced AIM2 pyroptosis halts aberrant inflammation during rhabdomyolysis-induced acute kidney injury. Cell Death Differ. 29, 2487\u20132502 https:\/\/doi.org\/10.1038\/s41418-022-01033-9 (2022).","journal-title":"Cell Death Differ."},{"key":"1120_CR133","doi-asserted-by":"publisher","first-page":"2530","DOI":"10.1093\/ndt\/gfq058","volume":"25","author":"H Machida","year":"2010","unstructured":"Machida, H. et al. Expression of Toll-like receptor 9 in renal podocytes in childhood-onset active and inactive lupus nephritis. Nephrol. Dial. Transpl. 25, 2530\u20132537 https:\/\/doi.org\/10.1093\/ndt\/gfq058 (2010).","journal-title":"Nephrol. Dial. Transpl."},{"key":"1120_CR134","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/7697592","volume":"2016","author":"F Conti","year":"2016","unstructured":"Conti, F. et al. Kidney expression of toll like receptors in lupus nephritis: quantification and clinicopathological correlations. Mediators Inflamm. 2016, 7697592 https:\/\/doi.org\/10.1155\/2016\/7697592 (2016).","journal-title":"Mediators Inflamm."},{"key":"1120_CR135","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1084\/jem.20050630","volume":"202","author":"CM Lau","year":"2005","unstructured":"Lau, C. M. et al. RNA-associated autoantigens activate B cells by combined B cell antigen receptor\/Toll-like receptor 7 engagement. J. Exp. Med. 202, 1171\u20131177 (2005).","journal-title":"J. Exp. Med."},{"key":"1120_CR136","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/416603a","volume":"416","author":"EA Leadbetter","year":"2002","unstructured":"Leadbetter, E. A. et al. Chromatin\u2013IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors. Nature 416, 603\u2013607 (2002).","journal-title":"Nature"},{"key":"1120_CR137","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1172\/JCI23025","volume":"115","author":"TK Means","year":"2005","unstructured":"Means, T. K. et al. Human lupus autoantibody\u2013DNA complexes activate DCs through cooperation of CD32 and TLR9. J. Clin. Invest. 115, 407\u2013417 (2005).","journal-title":"J. Clin. Invest."},{"key":"1120_CR138","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1084\/jem.20151876","volume":"213","author":"S Caielli","year":"2016","unstructured":"Caielli, S. et al. Oxidized mitochondrial nucleoids released by neutrophils drive type I interferon production in human lupus. J. Exp. Med. 213, 697\u2013713 https:\/\/doi.org\/10.1084\/jem.20151876 (2016).","journal-title":"J. Exp. Med."},{"key":"1120_CR139","doi-asserted-by":"publisher","first-page":"2009","DOI":"10.1681\/ASN.2015040376","volume":"27","author":"N Tsuji","year":"2016","unstructured":"Tsuji, N. et al. Role of mitochondrial DNA in septic AKI via Toll-like receptor 9. J. Am. Soc. Nephrol. 27, 2009\u20132020 https:\/\/doi.org\/10.1681\/ASN.2015040376 (2016).","journal-title":"J. Am. Soc. Nephrol."},{"key":"1120_CR140","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1096\/fj.03-0646fje","volume":"18","author":"HJ Anders","year":"2004","unstructured":"Anders, H. J. et al. Activation of toll-like receptor-9 induces progression of renal disease in MRL-Fas(lpr) mice. FASEB J. 18, 534\u2013536 https:\/\/doi.org\/10.1096\/fj.03-0646fje (2004).","journal-title":"FASEB J."},{"key":"1120_CR141","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1084\/jem.20050338","volume":"202","author":"SR Christensen","year":"2005","unstructured":"Christensen, S. R. et al. Toll-like receptor 9 controls anti-DNA autoantibody production in murine lupus. J. Exp. Med. 202, 321\u2013331 https:\/\/doi.org\/10.1084\/jem.20050338 (2005).","journal-title":"J. Exp. Med."},{"key":"1120_CR142","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2022.102894","volume":"132","author":"Y Xia","year":"2022","unstructured":"Xia, Y. et al. SB431542 alleviates lupus nephritis by regulating B cells and inhibiting the TLR9\/TGF\u03b21\/PDGFB signaling. J. Autoimmun. 132, 102894 https:\/\/doi.org\/10.1016\/j.jaut.2022.102894 (2022).","journal-title":"J. Autoimmun."},{"key":"1120_CR143","doi-asserted-by":"publisher","DOI":"10.1016\/j.humimm.2024.111104","volume":"85","author":"A Pati","year":"2024","unstructured":"Pati, A., Das, B. K. & Panda, A. K. Elevated toll-like receptor 9 is associated with disease severity and kidney involvement in systemic lupus erythematosus. Hum. Immunol. 85, 111104 https:\/\/doi.org\/10.1016\/j.humimm.2024.111104 (2024).","journal-title":"Hum. Immunol."},{"key":"1120_CR144","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1084\/jem.20082316","volume":"206","author":"R Fukui","year":"2009","unstructured":"Fukui, R. et al. Unc93B1 biases Toll-like receptor responses to nucleic acid in dendritic cells toward DNA- but against RNA-sensing. J. Exp. Med. 206, 1339\u20131350 https:\/\/doi.org\/10.1084\/jem.20082316 (2009).","journal-title":"J. Exp. Med."},{"key":"1120_CR145","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.jaut.2009.11.001","volume":"34","author":"ML Santiago-Raber","year":"2010","unstructured":"Santiago-Raber, M. L. et al. Critical role of TLR7 in the acceleration of systemic lupus erythematosus in TLR9-deficient mice. J. Autoimmun. 34, 339\u2013348 https:\/\/doi.org\/10.1016\/j.jaut.2009.11.001 (2010).","journal-title":"J. Autoimmun."},{"key":"1120_CR146","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1002\/art.40535","volume":"70","author":"T Celhar","year":"2018","unstructured":"Celhar, T. et al. Toll-like receptor 9 deficiency breaks tolerance to RNA-associated antigens and up-regulates Toll-like receptor 7 protein in Sle1 mice. Arthritis Rheumatol. 70, 1597\u20131609 https:\/\/doi.org\/10.1002\/art.40535 (2018).","journal-title":"Arthritis Rheumatol."},{"key":"1120_CR147","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.immuni.2006.07.013","volume":"25","author":"SR Christensen","year":"2006","unstructured":"Christensen, S. R. et al. Toll-like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus. Immunity 25, 417\u2013428 https:\/\/doi.org\/10.1016\/j.immuni.2006.07.013 (2006).","journal-title":"Immunity"},{"key":"1120_CR148","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/s41586-022-04642-z","volume":"605","author":"GJ Brown","year":"2022","unstructured":"Brown, G. J. et al. TLR7 gain-of-function genetic variation causes human lupus. Nature 605, 349\u2013356 (2022).","journal-title":"Nature"},{"key":"1120_CR149","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.172219","volume":"8","author":"HA Cosgrove","year":"2023","unstructured":"Cosgrove, H. A. et al. B cell-intrinsic TLR7 expression drives severe lupus in TLR9-deficient mice. JCI Insight 8, e172219 https:\/\/doi.org\/10.1172\/jci.insight.172219 (2023).","journal-title":"JCI Insight"},{"key":"1120_CR150","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1177\/0961203315622823","volume":"25","author":"YH Lee","year":"2016","unstructured":"Lee, Y. H., Choi, S. J., Ji, J. D. & Song, G. G. Association between toll-like receptor polymorphisms and systemic lupus erythematosus: a meta-analysis update. Lupus 25, 593\u2013601 https:\/\/doi.org\/10.1177\/0961203315622823 (2016).","journal-title":"Lupus"},{"key":"1120_CR151","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-024-01601-1","volume":"22","author":"T Wang","year":"2024","unstructured":"Wang, T. et al. MiR-574-5p activates human TLR8 to promote autoimmune signaling and lupus. Cell Commun. Signal. 22, 220 https:\/\/doi.org\/10.1186\/s12964-024-01601-1 (2024).","journal-title":"Cell Commun. Signal."},{"key":"1120_CR152","doi-asserted-by":"publisher","first-page":"3651","DOI":"10.1172\/JCI42081","volume":"120","author":"O Demaria","year":"2010","unstructured":"Demaria, O. et al. TLR8 deficiency leads to autoimmunity in mice. J. Clin. Invest. 120, 3651\u20133662 https:\/\/doi.org\/10.1172\/JCI42081 (2010).","journal-title":"J. Clin. Invest."},{"key":"1120_CR153","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1681\/ASN.2004100820","volume":"16","author":"PS Patole","year":"2005","unstructured":"Patole, P. S. et al. Viral double-stranded RNA aggravates lupus nephritis through Toll-like receptor 3 on glomerular mesangial cells and antigen-presenting cells. J. Am. Soc. Nephrol. 16, 1326\u20131338 https:\/\/doi.org\/10.1681\/ASN.2004100820 (2005).","journal-title":"J. Am. Soc. Nephrol."},{"key":"1120_CR154","doi-asserted-by":"publisher","DOI":"10.1080\/0886022X.2023.2224890","volume":"45","author":"T Karasawa","year":"2023","unstructured":"Karasawa, T. et al. Expression of interferon-stimulated gene 20 (ISG20), an antiviral effector protein, in glomerular endothelial cells: possible involvement of ISG20 in lupus nephritis. Ren. Fail. 45, 2224890 https:\/\/doi.org\/10.1080\/0886022X.2023.2224890 (2023).","journal-title":"Ren. Fail."},{"key":"1120_CR155","doi-asserted-by":"publisher","DOI":"10.1016\/j.labinv.2023.100190","volume":"103","author":"N Tatsumoto","year":"2023","unstructured":"Tatsumoto, N. et al. EGF-receptor-dependent TLR7 signaling in macrophages promotes glomerular injury in crescentic glomerulonephritis. Lab. Invest. 103, 100190 https:\/\/doi.org\/10.1016\/j.labinv.2023.100190 (2023).","journal-title":"Lab. Invest."},{"key":"1120_CR156","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24021339","volume":"24","author":"SL Ford","year":"2023","unstructured":"Ford, S. L. et al. Toll-like receptor 9 induced dendritic cell activation promotes anti-myeloperoxidase autoimmunity and glomerulonephritis. Int. J. Mol. Sci. 24, 1339 https:\/\/doi.org\/10.3390\/ijms24021339 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"1120_CR157","doi-asserted-by":"publisher","first-page":"2384","DOI":"10.1681\/ASN.2007121311","volume":"19","author":"H Suzuki","year":"2008","unstructured":"Suzuki, H. et al. Toll-like receptor 9 affects severity of IgA nephropathy. J. Am. Soc. Nephrol. 19, 2384\u20132395 https:\/\/doi.org\/10.1681\/ASN.2007121311 (2008).","journal-title":"J. Am. Soc. Nephrol."},{"key":"1120_CR158","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1016\/j.kint.2023.06.018","volume":"104","author":"YN Wang","year":"2023","unstructured":"Wang, Y. N. et al. MTMR3 risk alleles enhance toll like receptor 9-induced IgA immunity in IgA nephropathy. Kidney Int. 104, 562\u2013576 https:\/\/doi.org\/10.1016\/j.kint.2023.06.018 (2023).","journal-title":"Kidney Int."},{"key":"1120_CR159","doi-asserted-by":"publisher","first-page":"F238","DOI":"10.1152\/ajprenal.00313.2019","volume":"318","author":"Y Naito","year":"2020","unstructured":"Naito, Y. et al. IL-17A activated by Toll-like receptor 9 contributes to the development of septic acute kidney injury. Am. J. Physiol. Renal Physiol. 318, F238\u2013F247 https:\/\/doi.org\/10.1152\/ajprenal.00313.2019 (2020).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"1120_CR160","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1681\/ASN.2014090927","volume":"27","author":"MA Alikhan","year":"2016","unstructured":"Alikhan, M. A. et al. Endogenous toll-like receptor 9 regulates AKI by promoting regulatory T cell recruitment. J. Am. Soc. Nephrol. 27, 706\u2013714 https:\/\/doi.org\/10.1681\/ASN.2014090927 (2016).","journal-title":"J. Am. Soc. Nephrol."},{"key":"1120_CR161","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202300623R","volume":"37","author":"Z Li","year":"2023","unstructured":"Li, Z. et al. Loss of FUT8 in renal tubules ameliorates ischemia-reperfusion injury-induced renal interstitial inflammation transition to fibrosis via the TLR3-NF-\u03b1B pathway. FASEB J. 37, e23091 https:\/\/doi.org\/10.1096\/fj.202300623R (2023).","journal-title":"FASEB J."},{"key":"1120_CR162","doi-asserted-by":"publisher","DOI":"10.1016\/j.trim.2024.102066","volume":"85","author":"J Pei","year":"2024","unstructured":"Pei, J. et al. Transcriptomics-based exploration of shared M1-type macrophage-related biomarker in acute kidney injury after kidney transplantation and acute rejection after kidney transplantation. Transpl. Immunol. 85, 102066 https:\/\/doi.org\/10.1016\/j.trim.2024.102066 (2024).","journal-title":"Transpl. Immunol."},{"key":"1120_CR163","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1126\/science.1093620","volume":"303","author":"F Heil","year":"2004","unstructured":"Heil, F. et al. Species-specific recognition of single-stranded RNA via Toll-like receptor 7 and 8. Science 303, 1526\u20131529 (2004).","journal-title":"Science"},{"key":"1120_CR164","doi-asserted-by":"publisher","DOI":"10.1038\/s12276-023-00965-7","author":"J Kim","year":"2023","unstructured":"Kim, J., Kim, H. S. & Chung, J. H. Molecular mechanisms of mitochondrial DNA release and activation of the cGAS-STING pathway. Exp. Mol. Med. https:\/\/doi.org\/10.1038\/s12276-023-00965-7 (2023).","journal-title":"Exp. Mol. Med."},{"key":"1120_CR165","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2020.01.013","author":"CA Piantadosi","year":"2020","unstructured":"Piantadosi, C. A. Mitochondrial DNA, oxidants, and innate immunity. Free. Radic. Biol. Med. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2020.01.013 (2020).","journal-title":"Free. Radic. Biol. Med."},{"key":"1120_CR166","doi-asserted-by":"publisher","DOI":"10.1111\/acel.13622","volume":"21","author":"W Zhong","year":"2022","unstructured":"Zhong, W. et al. Defective mitophagy in aged macrophages promotes mitochondrial DNA cytosolic leakage to activate STING signaling during liver sterile inflammation. Aging Cell 21, e13622 https:\/\/doi.org\/10.1111\/acel.13622 (2022).","journal-title":"Aging Cell"},{"key":"1120_CR167","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-45044-1","volume":"15","author":"JI Jimenez-Loygorri","year":"2024","unstructured":"Jimenez-Loygorri, J. I. et al. Mitophagy curtails cytosolic mtDNA-dependent activation of cGAS\/STING inflammation during aging. Nat. Commun. 15, 830 https:\/\/doi.org\/10.1038\/s41467-024-45044-1 (2024).","journal-title":"Nat. Commun."},{"key":"1120_CR168","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1016\/j.cmet.2025.01.013","volume":"37","author":"PA Dumesic","year":"2025","unstructured":"Dumesic, P. A. et al. RBM43 controls PGC1alpha translation and a PGC1\u03b2-STING signaling axis. Cell Metab. 37, 742\u2013757.e8 https:\/\/doi.org\/10.1016\/j.cmet.2025.01.013 (2025).","journal-title":"Cell Metab."},{"key":"1120_CR169","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms13280","volume":"7","author":"M Xie","year":"2016","unstructured":"Xie, M. et al. PKM2-dependent glycolysis promotes NLRP3 and AIM2 inflammasome activation. Nat. Commun. 7, 13280 https:\/\/doi.org\/10.1038\/ncomms13280 (2016).","journal-title":"Nat. Commun."},{"key":"1120_CR170","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2024.1512916","author":"J Su","year":"2024","unstructured":"Su, J., Cheng, F. & Yuan, W. Unraveling the cGAS\/STING signaling mechanism: impact on glycerolipid metabolism and diseases. Front. Med. https:\/\/doi.org\/10.3389\/fmed.2024.1512916 (2024).","journal-title":"Front. Med."},{"key":"1120_CR171","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1009597","author":"MT Gomes","year":"2021","unstructured":"Gomes, M. T., Guimaraes, E. S. & Marinho, F. V. STING regulates metabolic reprogramming in macrophages via HIF-1\u03b1 during Brucella infection. PLoS Pathog. https:\/\/doi.org\/10.1371\/journal.ppat.1009597 (2021).","journal-title":"PLoS Pathog."},{"key":"1120_CR172","doi-asserted-by":"publisher","DOI":"10.5802\/crbiol.110","author":"I Vila","year":"2023","unstructured":"Vila, I. & Laguette, N. The unexpected role of the STING protein in lipid metabolism. Comptes Rendus Biol. https:\/\/doi.org\/10.5802\/crbiol.110 (2023).","journal-title":"Comptes Rendus Biol."},{"key":"1120_CR173","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.84890","author":"J Gong","year":"2024","unstructured":"Gong, J., Gao, X. & Ge, S. The role of cGAS-STING signalling in metabolic diseases: from signalling networks to targeted intervention. Int. J. Biol. Sci. https:\/\/doi.org\/10.7150\/ijbs.84890 (2024).","journal-title":"Int. J. Biol. Sci."},{"key":"1120_CR174","doi-asserted-by":"publisher","DOI":"10.1016\/j.devcel.2022.06.003","author":"R Donne","year":"2022","unstructured":"Donne, R., Saroul-Ainama, M. & Cordier, P. Replication stress triggered by nucleotide pool imbalance drives DNA damage and cGAS-STING pathway activation in NAFLD. Dev. Cell https:\/\/doi.org\/10.1016\/j.devcel.2022.06.003 (2022).","journal-title":"Dev. Cell"},{"key":"1120_CR175","doi-asserted-by":"publisher","DOI":"10.1080\/0886022X.2023.2292753","volume":"45","author":"H Niu","year":"2023","unstructured":"Niu, H. et al. CD36 deletion ameliorates diabetic kidney disease by restoring fatty acid oxidation and improving mitochondrial function. Ren. Fail. 45, 2292753 https:\/\/doi.org\/10.1080\/0886022X.2023.2292753 (2023).","journal-title":"Ren. Fail."},{"key":"1120_CR176","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1161\/HYPERTENSIONAHA.112.198770","volume":"61","author":"DJ Kennedy","year":"2013","unstructured":"Kennedy, D. J. et al. CD36 and Na\/K-ATPase-\u03b11 form a proinflammatory signaling loop in kidney. Hypertension 61, 216\u2013224 https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.112.198770 (2013).","journal-title":"Hypertension"},{"key":"1120_CR177","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.cmet.2021.12.007","volume":"34","author":"IK Vila","year":"2022","unstructured":"Vila, I. K. et al. STING orchestrates the crosstalk between polyunsaturated fatty acid metabolism and inflammatory responses. Cell Metab. 34, 125\u2013139.e8 https:\/\/doi.org\/10.1016\/j.cmet.2021.12.007 (2022).","journal-title":"Cell Metab."},{"key":"1120_CR178","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1016\/j.molcel.2025.03.008","volume":"85","author":"Z Tang","year":"2025","unstructured":"Tang, Z. et al. STING mediates lysosomal quality control and recovery through its proton channel function and TFEB activation in lysosomal storage disorders. Mol. Cell 85, 1624\u20131639.e5 https:\/\/doi.org\/10.1016\/j.molcel.2025.03.008 (2025).","journal-title":"Mol. Cell"},{"key":"1120_CR179","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2015.00052","volume":"2","author":"N Simon","year":"2015","unstructured":"Simon, N. & Hertig, A. Alteration of fatty acid oxidation in tubular epithelial cells: from acute kidney injury to renal fibrogenesis. Front. Med. 2, 52 https:\/\/doi.org\/10.3389\/fmed.2015.00052 (2015).","journal-title":"Front. Med."},{"key":"1120_CR180","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/nm.3762","volume":"21","author":"HM Kang","year":"2015","unstructured":"Kang, H. M. et al. Defective fatty acid oxidation in renal tubular epithelial cells has a key role in kidney fibrosis development. Nat. Med. 21, 37\u201346 https:\/\/doi.org\/10.1038\/nm.3762 (2015).","journal-title":"Nat. Med."},{"key":"1120_CR181","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1681\/ASN.2014121181","volume":"27","author":"SH Han","year":"2016","unstructured":"Han, S. H. et al. Deletion of lkb1 in renal tubular epithelial cells leads to CKD by altering metabolism. J. Am. Soc. Nephrol. 27, 439\u2013453 https:\/\/doi.org\/10.1681\/ASN.2014121181 (2016).","journal-title":"J. Am. Soc. Nephrol."},{"key":"1120_CR182","doi-asserted-by":"publisher","first-page":"F561","DOI":"10.1152\/ajprenal.00036.2017","volume":"313","author":"H Ding","year":"2017","unstructured":"Ding, H. et al. Inhibiting aerobic glycolysis suppresses renal interstitial fibroblast activation and renal fibrosis. Am. J. Physiol. Renal Physiol. 313, F561\u2013F575 https:\/\/doi.org\/10.1152\/ajprenal.00036.2017 (2017).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"1120_CR183","doi-asserted-by":"publisher","first-page":"5082","DOI":"10.26355\/eurrev_201808_15701","volume":"22","author":"M Li","year":"2018","unstructured":"Li, M., Jia, F., Zhou, H., Di, J. & Yang, M. Elevated aerobic glycolysis in renal tubular epithelial cells influences the proliferation and differentiation of podocytes and promotes renal interstitial fibrosis. Eur. Rev. Med. Pharmacol. Sci. 22, 5082\u20135090 https:\/\/doi.org\/10.26355\/eurrev_201808_15701 (2018).","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"1120_CR184","doi-asserted-by":"publisher","DOI":"10.1016\/j.semnephrol.2020.01.010","author":"GZ Quinn","year":"2020","unstructured":"Quinn, G. Z., Dhillon, P. & Susztak, K. It takes two to tango: the role of dysregulated metabolism and inflammation in kidney disease development. Semin. Nephrol. https:\/\/doi.org\/10.1016\/j.semnephrol.2020.01.010 (2020).","journal-title":"Semin. Nephrol."},{"key":"1120_CR185","doi-asserted-by":"publisher","DOI":"10.1016\/j.tcb.2022.03.012","author":"T Doke","year":"2022","unstructured":"Doke, T. & Susztak, K. The multifaceted role of kidney tubule mitochondrial dysfunction in kidney disease development. Trends Cell Biol. https:\/\/doi.org\/10.1016\/j.tcb.2022.03.012 (2022).","journal-title":"Trends Cell Biol."},{"key":"1120_CR186","doi-asserted-by":"publisher","first-page":"F1050","DOI":"10.1152\/ajprenal.00461.2007","volume":"294","author":"H Yasuda","year":"2008","unstructured":"Yasuda, H. et al. Chloroquine and inhibition of Toll-like receptor 9 protect from sepsis-induced acute kidney injury. Am. J. Physiol. Renal Physiol. 294, F1050\u2013F1058 https:\/\/doi.org\/10.1152\/ajprenal.00461.2007 (2008).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"1120_CR187","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.777197","volume":"12","author":"Y Murakami","year":"2021","unstructured":"Murakami, Y. et al. Anti-TLR7 antibody protects against lupus nephritis in NZBWF1 mice by targeting B cells and patrolling monocytes. Front. Immunol. 12, 777197 https:\/\/doi.org\/10.3389\/fimmu.2021.777197 (2021).","journal-title":"Front. Immunol."},{"key":"1120_CR188","doi-asserted-by":"publisher","first-page":"9237","DOI":"10.1073\/pnas.161293498","volume":"98","author":"S Bauer","year":"2001","unstructured":"Bauer, S. et al. Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition. Proc. Natl Acad. Sci. USA 98, 9237\u20139242 https:\/\/doi.org\/10.1073\/pnas.161293498 (2001).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1120_CR189","doi-asserted-by":"publisher","first-page":"2981","DOI":"10.1172\/jci67390","volume":"123","author":"JS Knight","year":"2013","unstructured":"Knight, J. S. et al. Peptidylarginine deiminase inhibition is immunomodulatory and vasculoprotective in murine lupus. J. Clin. Invest. 123, 2981\u20132993 https:\/\/doi.org\/10.1172\/jci67390 (2013).","journal-title":"J. Clin. Invest."},{"key":"1120_CR190","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adp1338","volume":"17","author":"AG Ibrahim","year":"2025","unstructured":"Ibrahim, A. G. et al. Augmentation of DNA exonuclease TREX1 in macrophages as a therapy for cardiac ischemic injury. Sci. Transl. Med. 17, eadp1338 https:\/\/doi.org\/10.1126\/scitranslmed.adp1338 (2025).","journal-title":"Sci. Transl. Med."},{"key":"1120_CR191","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2024.177028","volume":"984","author":"X Leng","year":"2024","unstructured":"Leng, X. et al. C-176 inhibits macrophage polarization towards M1-subtype and ameliorates LPS induced acute kidney injury. Eur. J. Pharmacol. 984, 177028 https:\/\/doi.org\/10.1016\/j.ejphar.2024.177028 (2024).","journal-title":"Eur. J. Pharmacol."},{"key":"1120_CR192","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-64348-y","volume":"10","author":"C Wiser","year":"2020","unstructured":"Wiser, C., Kim, B., Vincent, J. & Ascano, M. Small molecule inhibition of human cGAS reduces total cGAMP output and cytokine expression in cells. Sci. Rep. 10, 7604 https:\/\/doi.org\/10.1038\/s41598-020-64348-y (2020).","journal-title":"Sci. Rep."},{"key":"1120_CR193","doi-asserted-by":"publisher","first-page":"20273","DOI":"10.1021\/jacs.3c03637","volume":"145","author":"L Barasa","year":"2023","unstructured":"Barasa, L. et al. Development of LB244, an Irreversible STING Antagonist. J. Am. Chem. Soc. 145, 20273\u201320288 https:\/\/doi.org\/10.1021\/jacs.3c03637 (2023).","journal-title":"J. Am. Chem. Soc."},{"key":"1120_CR194","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.2025-0390.PV073","volume":"52","author":"X Valencia","year":"2025","unstructured":"Valencia, X. et al. Safety, tolerability, pharmacokinetics and pharmacodynamics in healthy volunteers of VENT-03, a novel cGAS inhibitor for the treatment of systemic lupus erythematosus. J. Rheumatol. 52, 121 https:\/\/doi.org\/10.3899\/jrheum.2025-0390.PV073 (2025).","journal-title":"J. Rheumatol."},{"key":"1120_CR195","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.bpj.2017.10.027","volume":"114","author":"AY Shih","year":"2018","unstructured":"Shih, A. Y., Damm-Ganamet, K. L. & Mirzadegan, T. Dynamic structural differences between human and mouse STING lead to differing sensitivity to DMXAA. Biophys. J. 114, 32\u201339 (2018).","journal-title":"Biophys. J."},{"key":"1120_CR196","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202300342RRR","volume":"37","author":"Z Feng","year":"2023","unstructured":"Feng, Z. et al. PCSK9 causes inflammation and cGAS\/STING pathway activation in diabetic nephropathy. FASEB J. 37, e23127 https:\/\/doi.org\/10.1096\/fj.202300342RRR (2023).","journal-title":"FASEB J."},{"key":"1120_CR197","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1056\/NEJMoa1500858","volume":"372","author":"MS Sabatine","year":"2015","unstructured":"Sabatine, M. S. et al. Efficacy and safety of evolocumab in reducing lipids and cardiovascular events. N. Engl. J. Med. 372, 1500\u20131509 https:\/\/doi.org\/10.1056\/NEJMoa1500858 (2015).","journal-title":"N. Engl. J. Med."},{"key":"1120_CR198","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/j.bja.2021.05.036","volume":"127","author":"N Arulkumaran","year":"2021","unstructured":"Arulkumaran, N. et al. Selective mitochondrial antioxidant MitoTEMPO reduces renal dysfunction and systemic inflammation in experimental sepsis in rats. Br. J. Anaesth. 127, 577\u2013586 https:\/\/doi.org\/10.1016\/j.bja.2021.05.036 (2021).","journal-title":"Br. J. Anaesth."},{"key":"1120_CR199","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.freeradbiomed.2025.05.431","volume":"237","author":"T Duan","year":"2025","unstructured":"Duan, T. et al. Mito-tempo ameliorates tubular injury of diabetic nephropathy via inhibiting mt-dsRNA release and PKR\/eIF2\u03b1 pathway activation. Free. Radic. Biol. Med. 237, 147\u2013159 https:\/\/doi.org\/10.1016\/j.freeradbiomed.2025.05.431 (2025).","journal-title":"Free. Radic. Biol. Med."},{"key":"1120_CR200","doi-asserted-by":"publisher","DOI":"10.3390\/cells12060838","volume":"12","author":"M Markowska","year":"2023","unstructured":"Markowska, M., Niemczyk, S. & Romejko, K. Melatonin treatment in kidney diseases. Cells 12, 838 https:\/\/doi.org\/10.3390\/cells12060838 (2023).","journal-title":"Cells"},{"key":"1120_CR201","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1126\/science.aav4011","volume":"366","author":"J Kim","year":"2019","unstructured":"Kim, J. et al. VDAC oligomers form mitochondrial pores to release mtDNA fragments and promote lupus-like disease. Science 366, 1531\u20131536 https:\/\/doi.org\/10.1126\/science.aav4011 (2019).","journal-title":"Science"},{"key":"1120_CR202","doi-asserted-by":"publisher","first-page":"34793","DOI":"10.1074\/jbc.M202191200","volume":"277","author":"SJ Clarke","year":"2002","unstructured":"Clarke, S. J., McStay, G. P. & Halestrap, A. P. Sanglifehrin A acts as a potent inhibitor of the mitochondrial permeability transition and reperfusion injury of the heart by binding to cyclophilin-D at a different site from cyclosporin A. J. Biol. Chem. 277, 34793\u201334799 https:\/\/doi.org\/10.1074\/jbc.M202191200 (2002).","journal-title":"J. Biol. Chem."},{"key":"1120_CR203","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCINTERVENTIONS.117.005487","volume":"10","author":"A Saad","year":"2017","unstructured":"Saad, A. et al. Phase 2a clinical trial of mitochondrial protection (Elamipretide) during stent revascularization in patients with atherosclerotic renal artery stenosis. Circ. Cardiovasc. Interv. 10, e005487 https:\/\/doi.org\/10.1161\/CIRCINTERVENTIONS.117.005487 (2017).","journal-title":"Circ. Cardiovasc. Interv."},{"key":"1120_CR204","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1080\/10717544.2018.1440445","volume":"25","author":"M Zhao","year":"2018","unstructured":"Zhao, M. et al. Control release of mitochondria-targeted antioxidant by injectable self-assembling peptide hydrogel ameliorated persistent mitochondrial dysfunction and inflammation after acute kidney injury. Drug. Deliv. 25, 546\u2013554 https:\/\/doi.org\/10.1080\/10717544.2018.1440445 (2018).","journal-title":"Drug. Deliv."},{"key":"1120_CR205","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.116804","volume":"176","author":"HL Huang","year":"2024","unstructured":"Huang, H. L., Cheng, N. & Zhou, C. X. Megalin-targeting and ROS-responsive elamipretide-conjugated polymeric prodrug for treatment of acute kidney injury. Biomed. Pharmacother. 176, 116804 https:\/\/doi.org\/10.1016\/j.biopha.2024.116804 (2024).","journal-title":"Biomed. Pharmacother."},{"key":"1120_CR206","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.tips.2018.12.003","volume":"40","author":"DM Kasumba","year":"2019","unstructured":"Kasumba, D. M. & Grandvaux, N. Therapeutic targeting of RIG-I and MDA5 might not lead to the same rome. Trends Pharmacol. Sci. 40, 116\u2013127 https:\/\/doi.org\/10.1016\/j.tips.2018.12.003 (2019).","journal-title":"Trends Pharmacol. Sci."},{"key":"1120_CR207","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1021\/acschembio.9b00810","volume":"15","author":"DC Rawling","year":"2020","unstructured":"Rawling, D. C., Jagdmann, G. E. Jr., Potapova, O. & Pyle, A. M. Small-molecule antagonists of the RIG-I innate immune receptor. ACS Chem. Biol. 15, 311\u2013317 https:\/\/doi.org\/10.1021\/acschembio.9b00810 (2020).","journal-title":"ACS Chem. Biol."},{"key":"1120_CR208","doi-asserted-by":"publisher","DOI":"10.1186\/s12929-024-01080-z","volume":"31","author":"RM Lu","year":"2024","unstructured":"Lu, R. M. et al. Current landscape of mRNA technologies and delivery systems for new modality therapeutics. J. Biomed. Sci. 31, 89 https:\/\/doi.org\/10.1186\/s12929-024-01080-z (2024).","journal-title":"J. Biomed. Sci."},{"key":"1120_CR209","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.kint.2020.01.036","volume":"98","author":"SJ Han","year":"2020","unstructured":"Han, S. J. et al. Selective nanoparticle-mediated targeting of renal tubular Toll-like receptor 9 attenuates ischemic acute kidney injury. Kidney Int. 98, 76\u201387 https:\/\/doi.org\/10.1016\/j.kint.2020.01.036 (2020).","journal-title":"Kidney Int."},{"key":"1120_CR210","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2024.138577","volume":"287","author":"Y Wang","year":"2025","unstructured":"Wang, Y. et al. Improved bioavailability of polydatin and its protective effect against cisplatin induced nephrotoxicity through self-assembled fucoidan and carboxymethyl chitosan delivery system. Int. J. Biol. Macromol. 287, 138577 https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.138577 (2025).","journal-title":"Int. J. Biol. Macromol."},{"key":"1120_CR211","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2023.125541","volume":"245","author":"X Gao","year":"2023","unstructured":"Gao, X. et al. Fucoidan-proanthocyanidins nanoparticles protect against cisplatin-induced acute kidney injury by activating mitophagy and inhibiting mtDNA-cGAS\/STING signaling pathway. Int. J. Biol. Macromol. 245, 125541 https:\/\/doi.org\/10.1016\/j.ijbiomac.2023.125541 (2023).","journal-title":"Int. J. Biol. Macromol."},{"key":"1120_CR212","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.actbio.2022.03.024","volume":"144","author":"Z Xia","year":"2022","unstructured":"Xia, Z. et al. Nanoformulation of a carbon monoxide releasing molecule protects against cyclosporin A-induced nephrotoxicity and renal fibrosis via the suppression of the NLRP3 inflammasome mediated TGF-\u03b2\/Smad pathway. Acta Biomater. 144, 42\u201353 https:\/\/doi.org\/10.1016\/j.actbio.2022.03.024 (2022).","journal-title":"Acta Biomater."},{"key":"1120_CR213","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202500141","volume":"14","author":"Y Du","year":"2025","unstructured":"Du, Y. et al. Synergistic provoking of pyroptosis and STING pathway by multifunctional manganese-polydopamine nano-immunomodulator for enhanced renal cell carcinoma immunotherapy. Adv. Healthc. Mater. 14, e2500141 https:\/\/doi.org\/10.1002\/adhm.202500141 (2025).","journal-title":"Adv. Healthc. Mater."},{"key":"1120_CR214","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202411254","volume":"12","author":"Q Chen","year":"2025","unstructured":"Chen, Q. et al. Hierarchical targeting nanodrug with holistic DNA protection for effective treatment of acute kidney injury. Adv. Sci. 12, e2411254 https:\/\/doi.org\/10.1002\/advs.202411254 (2025).","journal-title":"Adv. Sci."},{"key":"1120_CR215","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/s41587-025-02556-5","volume":"44","author":"MN Patel","year":"2026","unstructured":"Patel, M. N. et al. Safer non-viral DNA delivery using lipid nanoparticles loaded with endogenous anti-inflammatory lipids. Nat. Biotechnol. 44, 79\u201389 https:\/\/doi.org\/10.1038\/s41587-025-02556-5 (2026).","journal-title":"Nat. Biotechnol."},{"key":"1120_CR216","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2021.154748","volume":"118","author":"M Wu","year":"2021","unstructured":"Wu, M. et al. Inhibition of NLRP3 inflammasome ameliorates podocyte damage by suppressing lipid accumulation in diabetic nephropathy. Metabolism 118, 154748 https:\/\/doi.org\/10.1016\/j.metabol.2021.154748 (2021).","journal-title":"Metabolism"},{"key":"1120_CR217","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.kint.2025.11.017","volume":"109","author":"SJ Barbour","year":"2026","unstructured":"Barbour, S. J. et al. A single-arm phase 2 trial of an investigational RNA therapeutic to complement factor B sefaxersen for treatment of IgA nephropathy. Kidney Int. 109, 592\u2013601 https:\/\/doi.org\/10.1016\/j.kint.2025.11.017 (2026).","journal-title":"Kidney Int."},{"key":"1120_CR218","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-54475-9","volume":"15","author":"T Furusho","year":"2024","unstructured":"Furusho, T. et al. Enhancing gene transfer to renal tubules and podocytes by context-dependent selection of AAV capsids. Nat. Commun. 15, 10728 https:\/\/doi.org\/10.1038\/s41467-024-54475-9 (2024).","journal-title":"Nat. Commun."},{"key":"1120_CR219","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1038\/s41591-018-0049-z","volume":"24","author":"E Haapaniemi","year":"2018","unstructured":"Haapaniemi, E., Botla, S., Persson, J., Schmierer, B. & Taipale, J. CRISPR-Cas9 genome editing induces a p53-mediated DNA damage response. Nat. Med. 24, 927\u2013930 https:\/\/doi.org\/10.1038\/s41591-018-0049-z (2018).","journal-title":"Nat. Med."},{"key":"1120_CR220","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/s41591-018-0326-x","volume":"25","author":"CT Charlesworth","year":"2019","unstructured":"Charlesworth, C. T. et al. Identification of preexisting adaptive immunity to Cas9 proteins in humans. Nat. Med. 25, 249\u2013254 https:\/\/doi.org\/10.1038\/s41591-018-0326-x (2019).","journal-title":"Nat. Med."},{"key":"1120_CR221","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-56223-z","volume":"16","author":"S He","year":"2025","unstructured":"He, S. et al. High-density lipoprotein nanoparticles spontaneously target to damaged renal tubules and alleviate renal fibrosis by remodeling the fibrotic niches. Nat. Commun. 16, 1061 https:\/\/doi.org\/10.1038\/s41467-025-56223-z (2025).","journal-title":"Nat. Commun."},{"key":"1120_CR222","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-55522-1","volume":"16","author":"R Raghavan","year":"2025","unstructured":"Raghavan, R. et al. Rational engineering of minimally immunogenic nucleases for gene therapy. Nat. Commun. 16, 105 https:\/\/doi.org\/10.1038\/s41467-024-55522-1 (2025).","journal-title":"Nat. Commun."},{"key":"1120_CR223","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1158\/2159-8290.CD-24-0102","volume":"14","author":"SK Pal","year":"2024","unstructured":"Pal, S. K. et al. CD70-targeted allogeneic CAR T-cell therapy for advanced clear cell renal cell carcinoma. Cancer Discov. 14, 1176\u20131189 https:\/\/doi.org\/10.1158\/2159-8290.CD-24-0102 (2024).","journal-title":"Cancer Discov."},{"key":"1120_CR224","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-024-01653-5","volume":"44","author":"MM Thomsen","year":"2024","unstructured":"Thomsen, M. M. et al. Impaired STING activation due to a variant in the E3 ubiquitin ligase AMFR in a patient with severe VZV infection and hemophagocytic lymphohistiocytosis. J. Clin. Immunol. 44, 56 https:\/\/doi.org\/10.1007\/s10875-024-01653-5 (2024).","journal-title":"J. Clin. Immunol."},{"key":"1120_CR225","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-021-00391-8","volume":"6","author":"R Sartorius","year":"2021","unstructured":"Sartorius, R., Trovato, M., Manco, R., D\u2019Apice, L. & De Berardinis, P. Exploiting viral sensing mediated by toll-like receptors to design innovative vaccines. NPJ Vaccines 6, 127 https:\/\/doi.org\/10.1038\/s41541-021-00391-8 (2021).","journal-title":"NPJ Vaccines"},{"key":"1120_CR226","doi-asserted-by":"publisher","first-page":"8107","DOI":"10.1093\/nar\/gkac618","volume":"50","author":"AJ Pollak","year":"2022","unstructured":"Pollak, A. J. et al. Insights into innate immune activation via PS-ASO-protein-TLR9 interactions. Nucleic Acids Res. 50, 8107\u20138126 https:\/\/doi.org\/10.1093\/nar\/gkac618 (2022).","journal-title":"Nucleic Acids Res."},{"key":"1120_CR227","doi-asserted-by":"publisher","first-page":"23429","DOI":"10.1155\/jbb\/2006\/23429","volume":"2006","author":"M Sioud","year":"2006","unstructured":"Sioud, M. & Furset, G. Molecular basis for the immunostimulatory potency of small interfering RNAs. J. Biomed. Biotechnol. 2006, 23429 https:\/\/doi.org\/10.1155\/jbb\/2006\/23429 (2006).","journal-title":"J. Biomed. Biotechnol."},{"key":"1120_CR228","doi-asserted-by":"publisher","first-page":"2259","DOI":"10.1016\/j.bbamem.2009.06.022","volume":"1788","author":"SD Li","year":"2009","unstructured":"Li, S. D. & Huang, L. Nanoparticles evading the reticuloendothelial system: role of the supported bilayer. Biochim. Biophys. Acta 1788, 2259\u20132266 https:\/\/doi.org\/10.1016\/j.bbamem.2009.06.022 (2009).","journal-title":"Biochim. Biophys. Acta"},{"key":"1120_CR229","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/s41401-018-0052-4","volume":"40","author":"S Li","year":"2019","unstructured":"Li, S. et al. Design and evaluation of glomerulus mesangium-targeted PEG-PLGA nanoparticles loaded with dexamethasone acetate. Acta Pharmacol. Sin. 40, 143\u2013150 https:\/\/doi.org\/10.1038\/s41401-018-0052-4 (2019).","journal-title":"Acta Pharmacol. Sin."},{"key":"1120_CR230","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2403131121","volume":"121","author":"Y Huang","year":"2024","unstructured":"Huang, Y., Yu, M. & Zheng, J. Charge barriers in the kidney elimination of engineered nanoparticles. Proc. Natl Acad. Sci. USA 121, e2403131121 https:\/\/doi.org\/10.1073\/pnas.2403131121 (2024).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1120_CR231","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1038\/s41581-023-00702-3","volume":"19","author":"JL Peek","year":"2023","unstructured":"Peek, J. L. & Wilson, M. H. Cell and gene therapy for kidney disease. Nat. Rev. Nephrol. 19, 451\u2013462 https:\/\/doi.org\/10.1038\/s41581-023-00702-3 (2023).","journal-title":"Nat. Rev. Nephrol."},{"key":"1120_CR232","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtm.2024.101333","volume":"32","author":"N Tavakolidakhrabadi","year":"2024","unstructured":"Tavakolidakhrabadi, N., Ding, W. Y., Saleem, M. A., Welsh, G. I. & May, C. Gene therapy and kidney diseases. Mol. Ther. Methods Clin. Dev. 32, 101333 https:\/\/doi.org\/10.1016\/j.omtm.2024.101333 (2024).","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"1120_CR233","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/s41576-021-00439-4","volume":"23","author":"K Paunovska","year":"2022","unstructured":"Paunovska, K., Loughrey, D. & Dahlman, J. E. Drug delivery systems for RNA therapeutics. Nat. Rev. Genet. 23, 265\u2013280 https:\/\/doi.org\/10.1038\/s41576-021-00439-4 (2022).","journal-title":"Nat. Rev. Genet."},{"key":"1120_CR234","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1038\/ng.3434","volume":"47","author":"J Bentham","year":"2015","unstructured":"Bentham, J. et al. Genetic association analyses implicate aberrant regulation of innate and adaptive immunity genes in the pathogenesis of systemic lupus erythematosus. Nat. Genet. 47, 1457\u20131464 https:\/\/doi.org\/10.1038\/ng.3434 (2015).","journal-title":"Nat. Genet."},{"key":"1120_CR235","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-018-1604-1","volume":"20","author":"A Juli\u00e0","year":"2018","unstructured":"Juli\u00e0, A. et al. Genome-wide association study meta-analysis identifies five new loci for systemic lupus erythematosus. Arthritis Res. Ther. 20, 100 https:\/\/doi.org\/10.1186\/s13075-018-1604-1 (2018).","journal-title":"Arthritis Res. Ther."},{"key":"1120_CR236","doi-asserted-by":"publisher","first-page":"271","DOI":"10.3109\/08916934.2011.637532","volume":"45","author":"A Pontillo","year":"2012","unstructured":"Pontillo, A. et al. Polimorphisms in inflammasome genes are involved in the predisposition to systemic lupus erythematosus. Autoimmunity 45, 271\u2013278 https:\/\/doi.org\/10.3109\/08916934.2011.637532 (2012).","journal-title":"Autoimmunity"},{"key":"1120_CR237","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1053\/j.ajkd.2024.05.014","volume":"84","author":"S Volpi","year":"2024","unstructured":"Volpi, S. et al. Lupus nephritis patterns and response to Type I interferon in patients With DNASE1L3 variants: report of three cases. Am. J. Kidney Dis. 84, 791\u2013797 https:\/\/doi.org\/10.1053\/j.ajkd.2024.05.014 (2024).","journal-title":"Am. J. Kidney Dis."},{"key":"1120_CR238","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20201138","volume":"218","author":"J Hartl","year":"2021","unstructured":"Hartl, J. et al. Autoantibody-mediated impairment of DNASE1L3 activity in sporadic systemic lupus erythematosus. J. Exp. Med. 218, e20201138 (2021).","journal-title":"J. Exp. Med."},{"key":"1120_CR239","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1681\/asn.2022040477","volume":"34","author":"J Peng","year":"2023","unstructured":"Peng, J. et al. Clinical implications of a new DDX58 pathogenic variant that causes lupus nephritis due to RIG-I hyperactivation. J. Am. Soc. Nephrol. 34, 258\u2013272 https:\/\/doi.org\/10.1681\/asn.2022040477 (2023).","journal-title":"J. Am. Soc. Nephrol."},{"key":"1120_CR240","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.adx1135","volume":"10","author":"S Satoh","year":"2025","unstructured":"Satoh, S. et al. Local activation of mutant RIG-I by short noncoding Y-RNA in the kidney triggers lethal nephritis. Sci. Immunol. 10, eadx1135 https:\/\/doi.org\/10.1126\/sciimmunol.adx1135 (2025).","journal-title":"Sci. Immunol."},{"key":"1120_CR241","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.immuni.2013.12.014","volume":"40","author":"M Funabiki","year":"2014","unstructured":"Funabiki, M. et al. Autoimmune disorders associated with gain of function of the intracellular sensor MDA5. Immunity 40, 199\u2013212 https:\/\/doi.org\/10.1016\/j.immuni.2013.12.014 (2014).","journal-title":"Immunity"},{"key":"1120_CR242","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1056\/NEJMoa1312625","volume":"371","author":"Y Liu","year":"2014","unstructured":"Liu, Y. et al. Activated STING in a vascular and pulmonary syndrome. N. Engl. J. Med. 371, 507\u2013518 https:\/\/doi.org\/10.1056\/NEJMoa1312625 (2014).","journal-title":"N. Engl. J. Med."},{"key":"1120_CR243","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/j.jaip.2020.11.007","volume":"9","author":"ML Fr\u00e9mond","year":"2021","unstructured":"Fr\u00e9mond, M. L. et al. Overview of STING-associated vasculopathy with onset in infancy (SAVI) among 21 patients. J. Allergy Clin. Immunol. Pract. 9, 803\u2013818.e11 https:\/\/doi.org\/10.1016\/j.jaip.2020.11.007 (2021).","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"1120_CR244","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1053\/j.ajkd.2019.07.010","volume":"75","author":"Q Abid","year":"2020","unstructured":"Abid, Q. et al. APOL1-associated collapsing focal segmental glomerulosclerosis in a patient with stimulator of interferon genes (STING)-associated vasculopathy with onset in infancy (SAVI). Am. J. Kidney Dis. 75, 287\u2013290 https:\/\/doi.org\/10.1053\/j.ajkd.2019.07.010 (2020).","journal-title":"Am. J. Kidney Dis."}],"container-title":["Nature Reviews Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41581-026-01120-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41581-026-01120-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41581-026-01120-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T20:39:03Z","timestamp":1792096743000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41581-026-01120-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,1]]},"references-count":244,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["1120"],"URL":"https:\/\/doi.org\/10.1038\/s41581-026-01120-x","relation":{},"ISSN":["1759-5061","1759-507X"],"issn-type":[{"value":"1759-5061","type":"print"},{"value":"1759-507X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,1]]},"assertion":[{"value":"14 August 2026","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2026","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2026","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"In the version of this article initially published, Yeya Jang (Inje University College of Medicine, Busan, Republic of Korea; present address: Samsung Medical Center, Seoul, Republic of Korea) was listed with an incorrect affiliation; the affiliations are now amended in the HTML and PDF versions of the article.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}